Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

Hutchinson-Gilford Progeria Syndrome causes rapid aging from a genetic mutation, with no cure but ongoing research into potential treatments.

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

Researchers identified a new variant of the FGF5 gene in sheep that affects hair length.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Fish scale collagen peptide speeds up wound healing effectively.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Freeze-dried platelet-rich plasma boosts bone growth in gum treatment.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Certain gene variations are found in people with polycystic ovary syndrome.

People with polycystic ovary syndrome have higher levels of Gremlin-1.

Ghrelin and its receptors likely aren't risk factors for PCOS.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

New compounds were found to help increase hair growth and decrease hair loss.

2.5 mg/day finasteride effectively treats female pattern hair loss.